AEROCORT INHALER 50 MCG + 50 MCG

Description

The AEROCORT inhaler (50 mcg + 50 mcg) is a combined medication indicated for the management of the respiratory system in asthma, COPD, wheezing, and difficulty breathing. It consists of an antiasthmatic agent: Levosalbutamol is a bronchodilator that relaxes the muscles lining the air passages, while Beclometasone is a corticosteroid that reduces inflammation. In this manner, they increase airflow thus preventing shortness of breath and wheezing. This inhaler is a quick-relief medication for asthma and COPD situations while providing long-term control and maintenance, which makes it a good choice during acute and chronic management. Providing a rapid onset of action through inhalation, minimizes systemic side effects, thus ensuring that the patients maintain good respiratory health and quality of life.

Composition

Beclometasone Dipropionate (50 mcg): This steroidal compound reduces airway inflammation to prevent asthma attacks and facilitate breathing in conditions such as asthma and COPD.

Levosalbutamol (50 mcg): Levosalbutamol is a bronchodilator that relaxes muscles in the airways, relieving wheezing, shortness of breath, and breathing problems within a short period by opening up the air passages. 

Combined Action: Beclometasone Dipropionate and Levosalbutamol work to prevent and alleviate symptoms of asthma, COPD, and other respiratory disorders for long-term control and immediate relief.

Indications

The AEROCORT INHALER (50 MCG+50 MCG) is indicated for the management of asthma, chronic obstructive pulmonary disease (COPD), wheezing, and breathing difficulties. It combines a bronchodilator with a corticosteroid which reduces inflammation, dilates the airways, and aids in breathing to relieve symptoms and prevent exacerbations in the patient.

Conditions treated by AEROCORT Inhaler:

Treats Mild to Moderate Asthma: The AEROCORT Inhaler is a combination product, providing bronchodilation with anti-inflammatory activity to bring relief in symptoms such as breathlessness and wheezing in subjects suffering from mild to moderate asthma.

Management of Chronic Obstructive Pulmonary Disease (COPD): It plays a major part in controlling symptoms of COPD, which include chronic bronchitis and emphysema, by decreasing inflammation in the airways and enhancing airflow.

Wheezing and Difficulties Breathing Relief: The inhaler alleviates wheezing and any sort of breathing discomfort instigated by respiratory diseases, giving patients freer breathing and improved lung function.

Bronchospasm Relief: The AEROCORT Inhaler works perfectly for bronchial muscle relaxing, thus bringing almost immediate relief from bronchospasm making breathing easier for the patients experiencing the effects of bronchospasm.

Dual Action: It has both bronchodilator and corticosteroid activities, thus fitting in cases that need airway opening along with inflammation reduction.

Mechanism of Action

Beclomethasone Dipropionate produces anti-inflammatory effects by inhibiting the release of inflammatory mediators such as prostaglandins and leukotrienes and decreasing the recruitment of inflammatory cells to the airways. It binds to glucocorticoid receptors, down-regulating transcription of genes for pro-inflammatory proteins and up-regulating transcription of genes for anti-inflammatory proteins with the result of decreasing airway inflammation and swelling.

Levosalbutamol acts as a selective agonist for beta-2 adrenergic receptors on bronchial smooth muscle, thereby producing bronchodilation. Activation of these receptors produces relaxation of the muscles, dilation of the airways, and improvement in airflow, thus relieving wheeze and dyspnea within minutes.

The combination product shows synergism, enhancing therapeutic efficacy across the board. Beclometasone reduces inflammation and prevents long-term damage to the airways, while Levosalbutamol offers immediate relief from bronchoconstriction and ensures better control of asthma, COPD, and related symptoms.

Dosage and Administration

Recommended Dosage: The standard dose of AEROCORT INHALER (50 mcg + 50 mcg) administered is through inhalation of 1-2 puffs, 2-4 times daily, as the physician may prescribe. The dosage for children below 12 years of age should be decided by a doctor based on severity and response. 

Correct Usage: Shake well before each use. Exhale completely and place the mouthpiece between your lips. Inhale deeply through the mouth while pressing down on the canister. Hold your breath for ten seconds and then exhale slowly. Rinse your mouth following the treatment to avoid side effects.

When to Use: When prescribed, up to 1-2 puffs can be taken every 4-6 hours in addition to the prescribed dose to ease symptom relief. Patients should avoid self-dosing over their prescribed dosage without consulting their doctor. 

Monitoring: Maintain a record of your symptoms and call your doctor if no improvement is noticed with the use of AEROCORT INHALER or if the symptoms worsen.

Drug Interactions

Potential interactions between Aerocort inhaler (50 mcg + 50 mcg) and beta-adrenergic blockers may diminish its therapeutic efficacy in asthma or bronchial conditions since beta-blockers can induce bronchoconstriction. Conversely, respiratory diseases might be aggravated by the use of such non-selective beta-blockers.

When Aerocort is used with diuretics, the risk of hypokalemia may be enhanced, as the inhaler contains a corticosteroid (Beclometasone) and a bronchodilator (Levosalbutamol), which may lower potassium levels.

Inform your healthcare professional about all medications you take, including those available without a prescription. This includes vitamins, supplements, and herbal products, to prevent interactions and allow a physician to ensure the safe application of Aerocort Inhaler.

If Aerocort is used with other substances having effects on cardiac function and potassium homeostasis, then side effects can include increased heart rate, tremors, or electrolyte disturbances. Monitoring should be put in place for these side effects.

Side Effects

Common side effects:

The AEROCORT INHALER 50 MCG + 50 MCG could irritate the throat, leading to discomfort or a scratchy sensation in the throat.

Hoarseness may occur, which changes the person’s voice causing it to sound rough or strangled.

Some patients may develop tremors, which are involuntary shaking or tremors of their hands or other parts of their body.

Headaches are another common side effect, usually mild to moderate pain in the head. It is advisable to talk to your doctor in case these symptoms are persistent or worsening.

Rare but serious side effects:

Some users may experience an intense increase in heart rate due to the AEROCORT INHALER 50 MCG + 50 MCG, warranting immediate medical assistance should the heart rate worsen. 

Very severe allergic reactions will require discontinuation and urgent care if there is an unusual swelling of the face or tongue, skin rash, or difficulty in breathing.

Chronic use may lead to adrenal suppression, that is, in the ability of the body to produce its steroids, leading to possible side effects like fatigue, weakness, or low blood pressure.

Patients should be aware of any unusual symptoms and seek immediate consultation with a healthcare provider to best manage these rare but serious side effects.

Precautions and Warnings

Contraindications: The Cipla AeroCort Inhaler should not be administered to anyone who is hypersensitive to any of its ingredients, such as beclomethasone or salbutamol, since it may result in severe allergic reactions. Always advise your physician regarding any allergies you may have before taking the medication. 

Special Groups: Caution is advised in pregnant women, older persons, and children. Whenever indicated, the advice of a physician should be sought, as these groups may require altered dosing or enhanced observation to maximize safety and effectiveness.

Monitor For Side Effects: Regularly check for side effects such as throat irritation, tremors, increased heart rate, or oral thrush; and rinse out the mouth after every use to lower the risk of fungal infections.

Do Not Stop Abruptly: Use of the inhaler must not be stopped suddenly, even if symptoms ameliorate, delaying a serious exacerbation of asthma or COPD. Proper instructions should always be followed in tapering use as directed by a medical doctor.

Substitute

Think about switching to Singulair for efficient management of your asthma and allergies. Singulair 10 mg is appropriate for adults, while Singulair 5 mg is ideal for children. This oral medication works by blocking leukotrienes, thereby controlling symptoms through the reduction of inflammation and prevention of airway constriction. So if you want another option for better respiratory health besides an inhaler, you could choose Singulair.

Storage and Handling

Storage: The recommended storage temperature for AEROCORT cipla INHALER 50 MCG + 50 MCG stands between 15°C and 30°C. It requires storage at room temperature. The inhaler requires protection from both sunlight and heat while being shielded from all moisture. Store the inhaler without freezing and keep it dry at all times. Every time you do not use the inhaler it needs to be capped to avoid contamination.  

Shelf Life and Disposal: Users must check the expiration date on the carton before using the inhaler because the manufacturer sets a strict use-after date. Local waste disposal regulations should guide the disposal process for empty inhalers by ensuring they stay unused besides being discarded without puncturing or incinerating to safeguard environmental integrity.

Patient Counseling Points

Your healthcare professional will dictate the correct usage of the Cipla AeroCort Inhaler. The prescribed dosing schedule offers proper respiratory management thus preventing complications so never exceed recommended doses or skip scheduled medicine use.

You should train your breathing methods until the medicine reaches its target area inside your lungs. Pump the inhaler after shaking it and completely exhale before inhaling deeply by operating the canister. Sustain a ten-second breath after your inhalation to allow the medicine to reach proper absorption in your airways. 

Keep a lookout for any intensifying respiratory problems because shortness of breath wheezing and excessive use of rescue inhalers may appear while under treatment. A failure to maintain control of your symptoms may be indicated by these signs.

Medical help should be obtained immediately when signs and symptoms fail to improve with inhaler use or when side effects develop such as a sore throat or hoarseness or oral thrush. Medical emergency services combined with allergic reaction treatment become necessary for patients dealing with severe breathing complications.

Conclusion

Cipla AEROCORT inhaler provides strong asthma COPD and bronchospasm relief through its combined components of Levosalbutamol and Beclometasone. The use of this medication relaxes airway muscles to decrease inflammation which allows respiratory patients to breathe better.

Cipla inhaler which acts as both a maintenance and rescue therapy for providing immediate symptom relief while managing symptoms during long periods. The bronchodilator property of Levosalbutamol helps open the airways but Beclometasone functions as a corticosteroid that reduces swelling and eases airway irritation. The combination of these medications stops asthma attacks and contributes to better lung function.

References

Patients in the United States should use SYMBICORT which contains budesonide and formoterol because this medication has received FDA approval while AEROCORT with its ingredients of beclomethasone dipropionate and levosalbutamol does not have U.S. authorization. Scientific research has established the efficiency of this treatment for asthma control. The Food and Drug Administration operates a platform that provides clinical trial data along with instructions about the proper use of SYMBICORT.

Referral site: practo.com